- Home
- KNSA vs BMA Comparison
KNSA vs BMA Comparison
Compare KNSA & BMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | BMA |
|---|---|---|
| Founded | 2015 | 1966 |
| Country | United Kingdom | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.9B |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | KNSA | BMA |
|---|---|---|
| Price | $77.47 | $80.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $60.86 | ★ $99.33 |
| AVG Volume (30 Days) | ★ 686.4K | 233.8K |
| Earning Date | 04-28-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 4.99% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $16.25 |
| Revenue Next Year | $17.87 | N/A |
| P/E Ratio | $285.48 | ★ $33.22 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $32.69 | $38.30 |
| 52 Week High | $82.94 | $106.15 |
Technical Indicators
Market Signals| Indicator | KNSA | BMA |
|---|---|---|
| Relative Strength Index (RSI) | 65.81 | 35.74 |
| Support Level | $40.06 | $66.99 |
| Resistance Level | $82.94 | $95.14 |
| Average True Range (ATR) | 3.75 | 4.37 |
| MACD | 0.20 | -1.32 |
| Stochastic Oscillator | 76.67 | 1.17 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About BMA Banco Macro S.A. ADR (representing Ten Class B)
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. The company generates the majority of its revenue from Argentina.